Henri Juhani Huttunen
Fondateur chez HERANTIS PHARMA OYJ
Provenance du réseau au premier degré de Henri Juhani Huttunen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
Hermo Pharma Oy
 Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently untreatable medical needs, particularly in the field of neurology. The company's R&D programs are based on scientifically innovative concepts. These concepts are being developed through preclinical and early clinical development phases with the aim gaining partners prior to late clinical development phases and finally marketing. The company was founded in 2008 by professors Mart Saarma, Eero Castrén, Heikki Rauvala and Dr. Henri Huttunen. The company operates in close collaboration with several academic laboratories affiliated with the University of Helsinki. Hermo Pharma Ltd. operates according to the 'virtual business model'. This means the company outsources the majority of business functions outside of its core business areas, while controlling the key technology assets and strategic partnerships with a small but highly capable group of people managing operations. As the company's overheads are kept lower than traditional biopharmaceutical companies much more of its financial resources can be utilized directly to achieve business goals. Hermo Pharma Ltd. is a privately owned, venture capital backed company. Its current investors include Helsinki University Funds and Seed Fund Vera Ltd.
11
| Extinct | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Henri Juhani Huttunen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| VARIAN MEDICAL SYSTEMS, INC. | Medical Specialties | Corporate Officer/Principal | |
| REVVITY, INC. | Medical Specialties | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| PAION AG | Pharmaceuticals: Major | Chief Executive Officer | |
Insense Ltd.
 Insense Ltd. BiotechnologyHealth Technology Insense Ltd. develops products for treatment of wounds and skin conditions. Its development activity is concentrated on dermatology products for both professional and consumer applications. The company was founded in 2001 by Paul James Davis and is headquartered in Bedford, the United Kingdom. | Biotechnology | Director/Board Member | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
| ACCENTURE PLC | Information Technology Services | Corporate Officer/Principal | |
Organon NV
 Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Undergraduate Degree Corporate Officer/Principal | |
Orion Pharma Oy
 Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| NEL ASA | Industrial Machinery | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Mobidiag Oy
 Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Director/Board Member Founder Corporate Officer/Principal | |
| FARON PHARMACEUTICALS OY | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oulu | College/University | Undergraduate Degree | |
| University of Kuopio | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Helsinki | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Chairman Chief Executive Officer | |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | President | |
Paion Deutschland GmbH
 Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Biotechnology | Chief Executive Officer | |
| Baxter Medical AB | Corporate Officer/Principal | ||
| BERGENBIO ASA | Pharmaceuticals: Major | Chairman | |
| Suomen Bioteollisuus ry | Chairman Chairman | ||
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Founder | |
MediSapiens Oy
 MediSapiens Oy Packaged SoftwareTechnology Services MediSapiens Oy provides solutions for bioinformatics analysis. It offers software and products for biological research. The firm creates customized bioinformatics software solutions to organizations; ranging from data management system, to full sample and data processing system, to an animal deoxyribonucleic acid testing service. Its products include Biond Explorer; Research Integrator; IST Online; Target Scout; and Fusion Scout. The company was founded by Sami Kalevi Kilpinen, Olli-Pekka Kallioniemi, and Tommi Pisto in 2009 and is headquartered in Helsinki, Finland. | Packaged Software | Director/Board Member Director/Board Member | |
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chief Executive Officer Chairman Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Aplagon Oy
 Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| Aalto University School of Business | College/University | Masters Business Admin Graduate Degree | |
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
| BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Me AS
 Bio-Me AS BiotechnologyHealth Technology Bio-Me AS operates as a boi-tech firm. It researches and develops patented technologies and new approaches in bacteria analysis. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
| Eusa Pharma Europe Ltd. | President | ||
| Tappin AS | Director/Board Member | ||
| ONCOZENGE AB | Pharmaceuticals: Major | Director/Board Member | |
| Aalto University School of Science & Technology | College/University | Graduate Degree Doctorate Degree | |
BiopSense Oy
 BiopSense Oy BiotechnologyHealth Technology BiopSense Oy is a Finnish medical technology company that specializes in liquid biopsy services and technology development. The company is based in Jyvaskyla, Finland. BiopSense was founded by Marja Tiirola, Juha Kononen, and Veli-Mikko Puupponen, with Marja Tiirola serving as the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Finlande | 21 |
| Norvège | 10 |
| Suède | 7 |
| Royaume-Uni | 6 |
| Etats-Unis | 4 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 7 |
| Technology Services | 4 |
| Commercial Services | 3 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 128 |
| Corporate Officer/Principal | 61 |
| Chief Executive Officer | 34 |
| Chairman | 31 |
| Independent Dir/Board Member | 27 |
Relations les plus connectées
- Bourse
- Insiders
- Henri Juhani Huttunen
- Connexions Sociétés
